首页> 外文期刊>Scientific reports. >Genipin and EDC crosslinking of extracellular matrix hydrogel derived from human umbilical cord for neural tissue repair
【24h】

Genipin and EDC crosslinking of extracellular matrix hydrogel derived from human umbilical cord for neural tissue repair

机译:衍生自人脐带细胞外基质水凝胶的Genipin和EDC交联,用于神经组织修复

获取原文
       

摘要

Extracellular matrix (ECM) hydrogels, produced by tissue decellularization are natural injectable materials suitable for neural tissue repair. However, the rapid biodegradation of these materials may disrupt neural tissue reconstruction in vivo. The aim of this study was to improve the stability of the previously described ECM hydrogel derived from human umbilical cord using genipin and N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC), crosslinking at concentration of 0.5-10?mM. The hydrogels, crosslinked by genipin (ECM/G) or EDC (ECM/D), were evaluated in vitro in terms of their mechanical properties, degradation stability and biocompatibility. ECM/G, unlike ECM/D, crosslinked hydrogels revealed improved rheological properties when compared to uncrosslinked ECM. Both ECM/G and ECM/D slowed down the gelation time and increased the resistance against in vitro enzymatic degradation, while genipin crosslinking was more effective than EDC. Crosslinkers concentration of 1?mM enhanced the in vitro bio-stability of both ECM/G and ECM/D without affecting mesenchymal stem cell proliferation, axonal sprouting or neural stem cell growth and differentiation. Moreover, when injected into cortical photochemical lesion, genipin allowed in situ gelation and improved the retention of ECM for up to 2 weeks without any adverse tissue response or enhanced inflammatory reaction. In summary, we demonstrated that genipin, rather than EDC, improved the bio-stability of injectable ECM hydrogel in biocompatible concentration, and that ECM/G has potential as a scaffold for neural tissue application.
机译:通过组织脱细胞化产生的细胞外基质(ECM)水凝胶是适用于神经组织修复的天然可注射材料。然而,这些材料的快速生物降解可能破坏体内神经组织重建。本研究的目的是使用Genipin和N-(3-二甲基氨基丙基)-N'-乙基碳二亚胺盐酸盐(EDC)来改善先前描述的ECM水凝胶的稳定性,盐酸盐(EDC),交联0.5-10Ωmm 。通过Genipin(ECM / G)或EDC(ECM / D)交联的水凝胶在其机械性能,降解稳定性和生物相容性方面进行了体外评估。与ECM / D不同,交联水凝胶不同,与未交联的ECM相比,交联水凝胶显示出改善的流变性质。 ECM / G和ECM / D都减慢了凝胶化时间并增加了对体外酶促降解的阻力,而Genipin交联比EDC更有效。交联剂浓度为1?mm增强了ECM / g和ECM / D的体外生物稳定性,而不影响间充质干细胞增殖,轴突发芽或神经干细胞生长和分化。此外,当注射到皮质光化学病变中时,Genipin允许原位凝胶化,并改善了ECM长达2周的ECM,而没有任何不利的组织反应或增强的炎症反应。总之,我们证明了Genipin而不是EDC,改善了生物相容性浓度的可注射ECM水凝胶的生物稳定性,并且ECM / g具有用于神经组织应用的支架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号